← FDA DRUG APPROVALS

FDA NDA · NDA019134

HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER

Sponsor: B BRAUN

APPLICATION
NDA019134
TYPE
NDA
ORIGINAL APPROVAL
1985-03-29
LATEST ACTION
1992-04-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
HEPARIN SODIUM 5,000 UNITS/100ML · INJECTABLE · INJECTION

Approval history

1992-04-20Manufacturing (CMC) · Supplement 8 · standardAP
1990-03-30Manufacturing (CMC) · Supplement 7 · standardAP
1988-11-22Labeling · Supplement 6 · standardAP
1987-12-29Labeling · Supplement 4 · standardAP
1987-08-04Labeling · Supplement 3 · standardAP
1986-10-21Manufacturing (CMC) · Supplement 2 · standardAP
1985-09-10Labeling · Supplement 1 · standardAP
1985-03-29Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →